A Double Blind, Active Controlled Crossover Study to Evaluate the Efficacy and Safety of Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for the Management of Breakthrough Pain in Opioid Tolerant Patients With Chronic Pain.

Trial Profile

A Double Blind, Active Controlled Crossover Study to Evaluate the Efficacy and Safety of Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for the Management of Breakthrough Pain in Opioid Tolerant Patients With Chronic Pain.

Completed
Phase of Trial: Phase III

Latest Information Update: 25 May 2012

At a glance

  • Drugs Fentanyl (Primary) ; Oxycodone
  • Indications Pain
  • Focus Therapeutic Use
  • Sponsors Cephalon
  • Most Recent Events

    • 25 May 2012 Company added in the association field as reported by ClinicalTrials.gov.
    • 02 Sep 2010 Results were reported at the 13th World Congress on Pain.
    • 26 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top